SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ngl Fine-Chem informs about disclosure

18 Jun 2024 Evaluate
Ngl Fine-Chem has informed that the Company has received Certificate of suitability No. CEP 2022-025 - Rev 00, from European Directorate for the Quality of Medicines & Healthcare (EDQM) for its product Triclabendazole. This certificates facilitates registration and use of Triclabendazole manufactured by NGL Fine-Chem by the European customers for their finished product.

The above information is a part of company’s filings submitted to BSE.

NGL Fine-Chem Share Price

3180.60 243.15 (8.28%)
03-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1904.65
Dr. Reddys Labs. 1374.55
Cipla 1458.45
Zydus Lifesciences 1141.00
Lupin 2476.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: